Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy
β Scribed by Min Yi; Funda Meric-Bernstam; Lavinia P. Middleton; Banu K. Arun; Isabelle Bedrosian; Gildy V. Babiera; Rosa F. Hwang; Henry M. Kuerer; Wei Yang; Kelly K. Hunt
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 136 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background and objectives: Occult invasive cancer found in reduction mammaplasty specimen in the contralateral breast in breast cancer patients requires axillary lymph node dissection (alnd) to assess the lymph node status. routine sentinel node (sn) biopsy in these patients may avoid secondary
Inflammatory carcinoma of the breast is rare and lethal. Since the early 1940s, operation except for biopsy has been contraindicated in patients with inflammatory breast cancer. Results with radiotherapy alone and with radiotherapy and chemotherapy are reviewed. Results of treating patients with ini
## Abstract ## BACKGROUND The incidence of immunohistochemistry (IHC)βdetected epithelial cell displacement in sentinel lymph node (SLN) biopsy is unknown. In the current study, we address this question by examining the pattern of SLN involvement in patients undergoing prophylactic mastectomy (PM)